mnmhealthcare

Growth in this market is mainly driven by the increasing incidence and prevalence of cardiovascular disease, government initiatives in China, and the increasing number of hospitals.

• The China cardiology information system market is projected to reach $54 million by 2024 from $35 million in 2019, at a CAGR of 8.9% during the forecast period.
  
  

Cardiology Information System (CIS) Market by System (Standalone, Integrated System, Cardiology Information System, Cardiology PACS), Component (Software, Services, Hardware), & End User (L3A Hospital, L3B and L2 Hospital) – China Forecast to 2024

The software segment accounted for the largest share of the China cardiology information system market in 2018

By component, the market is segmented into software, services, and hardware. The software segment accounted for the largest market share in 2018. The large share of this segment can be attributed to the growing need to integrate CVIS with C-PACS, EMRs, and other cardiology modules.

Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=264168583

1.China Cardiology Information System Market, by System

• Integrated Systems
• Standalone Systems
  
  

2. China Cardiology Information System Market, by Component

• Software
• Services
• Hardware
  
  

3. China Cardiology Information System Market, by End User

• L3A Hospitals
• L3B and L2 Hospitals
  
  

The integrated systems segment is expected to grow at the highest CAGR during the forecast period

Based on system, the market is segmented into integrated and standalone systems. The integrated systems segment is projected to witness the highest growth during the forecast period. The increasing adoption of integrated systems by healthcare providers is the major factor supporting the growth of this segment.

Request for Sample Pages @https://www.marketsandmarkets.com/requestsampleNew.asp?id=264168583

L3A hospitals accounted for the largest share of the China cardiology information system market in 2018

Based on end user, the market is segmented into L3A hospitals and L3B & L2 Hospitals. The L3A hospitals segment accounted for the largest share of the market in 2018. The increasing number of L3A hospitals in China and growing disease prevalence are responsible for the large share of this market segment.

Some key players mentioned in the research report are:

Key players in the China cardiology information system market are Philips Healthcare (Netherlands), CREALIFE Medical Technology (China), Central Data Network (Australia), Infinitt Healthcare (South Korea) and Esaote (Italy).

In 2018, CREALIFE Medical Technology held the leading position in the market. The company has good relations with government bodies, distributors, and hospitals in the market, which is its key strength. Philips Healthcare held the second position in the market in 2018.

Growth in this market is primarily driven by the increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics.

• The global infectious disease diagnostics market was valued at USD 13.93 Billion in 2016 and projected to reach USD 19.35 Billion in 2022, at a CAGR of 5.6%.
  
  

What Drives the Market?

1. Increasing global prevalence of infectious diseases
2. Shift in focus from centralized laboratories to decentralized point-of-care testing
3. Growth in funding for research on infectious disease diagnostics

Get a sample PDF copy of the Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589

The global prevalence of infectious diseases such as influenza, HPV, hepatitis, HIV, and tuberculosis is considerably high in spite of significant improvements in sanitation practices and medicine. Many of the currently available diagnostic techniques are slow, involve complex procedures, and lack specific identification of causative agents.

On the basis of disease type, the infectious disease diagnostics (IDD) market is segmented into a wide range of diseases. Hospital acquired infections (HAI) segment to record the highest CAGR during the forecast period. Growth in HAI segment can be attributed to the rising burden of MRSA infections, the increasing number of new products launched in the market, and increasing adoption of technologically advanced HAI diagnostic tests such as BD MAX Cdiff assay, Xpert MRSA NxG, and ARIES C. difficile Assay that are based on PCR technology

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific
4. Rest of the World (RoW)

North America accounted for the largest share of the global infectious disease diagnostics market. The large share of this region is mainly attributed to the presence of a highly developed healthcare system, increasing prevalence of infectious diseases, the presence of a large number of leading national clinical laboratories, and easy accessibility to technologically advanced instruments in the region.

Some key players mentioned in the research report are:

Abbott Laboratories, Becton, Dickinson and Company, Biomérieux SA, Bio-Rad Laboratories, Danaher Corporation, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific

Get Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589

Rising government investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are the key factors driving the growth of this market. China, India, Japan, Korea, and Brazil are emerging markets for cell therapy instruments.

 The global cell therapy technologies market is projected to reach USD 19.9 billion by 2023 from USD 10.2 billion in 2018, at a CAGR of 14.4% during the forecast period. 

Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Cell Type (Human Stem & Differentiated, Animal), Process Stages (Cell Processing, Distribution, Handling, QC), End User, and Region – Global Forecast to 2023

What Drives the Market?

1. Rising Government Investments in Cell-Based Research
2.  Large Number of Oncology-Oriented Cell-Based Therapy Clinical Trials
4.  Affordability and Sustainability of Advanced Cell Therapy Instruments

Based on cell type, the market is segmented into human cells and animal cells. In 2018, the human cells segment is expected to account for the largest share of the cell therapy technologies market. The rising adoption of human cells over animal cells for cell therapeutics research, technological advancements, and the rising incidence of diseases such as cancer and cardiac abnormalities are the key factors driving the growth of this segment.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978

By product, the cell therapy technologies market is segmented into consumables, equipment, and systems & software. The consumables segment is expected to account for the largest share of the market in 2018. Factors such as increasing investments by companies to develop advanced products as well as government initiatives for enhancing cell-based research are contributing to the growth of the cell therapy consumables market.

Based on end user, the cells therapy instruments market is segmented into life science research companies and research institutes. The life science research companies segment is expected to dominate the market in 2018 as well as grow at the highest CAGR during the forecasted period.

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific    (APAC)
4. Rest of the World

The market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the market in 2018 owing to the high burden of chronic diseases and increasing R&D activities in the pharmaceutical and biotechnology industries. The Asia Pacific region is expected to register the highest CAGR during the forecast period.

Request Sample Report of  cell therapy technologies market @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978

Some key players mentioned in the research report are:

Key players in this cell therapy technologies market include Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT (US), and Thermo Fisher Scientific (US).

Recent Developments:

• In 2018, Thermo Fisher Scientific launched a new series of compact refrigerators.
• In 2018, Thermo Fisher Scientific launched an advanced laboratory management system for data integrity and complete regulatory compliance.
• In 2018, Lonza opened its Collaborative Innovation Center in Haifa, Israel.
• In 2018, Sartorius will offer current and future Lonza media and buffers on a non-exclusive basis as part of its extensive portfolio of products for cell-based development and manufacturing.
• In 2017, GE Healthcare acquired Asymptote (UK) in order to strengthen its cell therapy portfolio with a suite of technologies for the cryopreservation of cellular materials.
  
  

To get a 10% Customization on the report, click@ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=213334978

The growth of this market is primarily attributed to factors such as the increasing demand for synthetic genes & synthetic cells, wide range of applications of synthetic biology, declining cost of DNA sequencing & synthesizing, increasing R&D funding & initiatives in synthetic biology, and increasing investments in the market.

Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), by Technology (Gene Synthesis, Bioinformatics), by Application (Tissue Regeneration, Biofuel, Renewable Energy, Food & Agriculture, Bioremediation) – Global Forecast to 2025

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=889

How much is the Synthetic Biology Market worth?

The synthetic biology market is projected to reach USD 19.8 billion by 2025 from USD 6.8 billion in 2020, at a CAGR of 23.9%. The growth of this market is primarily attributed to factors such as the increasing demand for synthetic genes & synthetic cells, wide range of applications of synthetic biology, declining cost of DNA sequencing & synthesizing, increasing R&D funding & initiatives in synthetic biology, and increasing investments in the market.

Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889

Gene synthesis accounted for the largest share of the synthetic biology market in 2019 :

Based on technology, the market is segmented into gene synthesis, genome engineering, cloning, sequencing, site-directed mutagenesis, measurement & modeling, microfluidics, nanotechnology, and bioinformatics technologies. In 2019, the gene synthesis segment accounted for the largest share of the market.

The report claims to split the Regional Scope of the Focused synthetic biology Market into

• North America (US and Canada)
• Europe (Germany, France, UK, Spain, RoE, Denmark, Switzerland & Italy)
• Asia-Pacific (China, Japan, India, Australia and Rest of Asia Pacific)
• Rest of World (Latin America, Middle East & Africa)
  
  

The APAC market is expected to grow at the highest CAGR during the forecast period

The market in the Asia Pacific is expected to grow at the highest CAGR during the forecast period. Factors such as growth in the number of pharmaceutical & biopharmaceutical companies, the increasing number of healthcare & life science facilities, and increasing requirements for regulatory compliance in pharmaceutical and biopharmaceutical companies, growing number of international alliances, heavy funding for synthetic biology research, and strong government support are expected to drive the growth of these markets during the forecast period.

Which are the key players in the synthetic biology market and how intense is the competition?

The prominent players in the synthetic biology market are

 Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Novozymes A/S (Denmark), Ginkgo Bioworks (US), Amyris, Inc. (US), Intrexon Corporation (US), GenScript Biotech Corporation (China), Twist Bioscience (US), Synthetic Genomics, Inc. (US), Codexis, Inc. (US), Synthego Corporation (US), Creative Enzymes (US), Eurofins Scientific (Luxembourg), Cyrus Biotechnology Inc. (US), ATUM (US), TeselaGen (US), Arzeda (US), Integrated DNA Technologies, Inc. (US), and New England Biolabs (US).

To get a 10% Customization on the report,
click@ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=889

• The global bioinformatics market is expected to account for USD 7,063.7 billion in 2018. It is expected to reach USD 13,901.5 billion by 2023, at a CAGR of 14.5% during the forecast period.

What Drives the Market?
1.  Growing Demand for Nucleic Acid and Protein Sequencing Due to Reduction in Sequencing Cost and Technological Advancement
2.  Initiatives From Government and Private Organizations
3.  Growing Applications of Bioinformatics
4.  Number of Collaborations Between Companies and Research Institutes

By the  Product & Service, the market is primarily split into :  Knowledge Management Tools, Data Analysis Platforms (Structural & Functional), Services

 

By the  Applications, the market is primarily split into :  Genomics, Proteomics & Metabolomics

By the  Sectors, the market is primarily split into : Medical, Academics, Agriculture

 

Growth of the bioinformatics market is driven by the growing demand for nucleic acid and protein sequencing, increasing government initiatives and funding, and increasing use of bioinformatics in drug discovery and biomarker development processes. With the introduction of upcoming technologies such as nanopore sequencing (third generation sequencing technique) and cloud computing, the market is expected to offer significant opportunities for manufacturers of bioinformatics solutions.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39

Knowledge management tools commanded the largest market share in the global bioinformatics market in 2018, while the bioinformatics platforms segment is expected to be the fastest-growing segment in the forecast period. The major factor driving growth of bioinformatics platforms is their growing use in various genomic applications.

Factors such as the availability of research funding and government support are fueling market growth. However, metabolomes cannot be easily identified or figured from reconstructed biochemical pathways due to enzymatic diversity, substrate ambiguity, and difference in regulatory mechanisms. Hence, the annotation of unknown metabolic signals is the main hindrance to growth of the metabolomics segment.

The report claims to split the Regional Scope of the Bioinformatics Market  into

• Asia-Pacific (Japan, China, India, RoAPAC)
• North America (US and Canada)
• Europe (Germany, France, UK and RoE)
• Rest of World

Growth in this market is driven majorly by the rising R&D spending in the pharmaceutical & biopharmaceutical industry, growing demand for membrane filtration technology, increasing purity requirements in end-user segments, and growing focus on developing large-molecule biopharmaceuticals.

The global laboratory filtration market size is projected to reach USD 4.1 billion by 2025 from USD 2.5 billion in 2019, at a CAGR of 8.3% during the forecast period.

Laboratory Filtration Market by Product (Filtration Assembly, Filter Media Accessories), Technology (Ultrafiltration, Microfiltration, Nanofiltration, RO), End User (Pharmaceutical, Biopharmaceutical Company, F&B), Region – Global Forecast to 2025

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12936082

Global Medical Bed Market is Segmented on:

1. Product
2. Technology
3. End User

Type

Based on product, the market is segmented into filtration media (filter papers, membrane filters, syringe and syringeless filters, filtration microplates, and other filtration media), filtration assemblies (microfiltration assemblies, reverse osmosis assemblies, ultrafiltration assemblies, vacuum filtration assemblies, and other filtration assemblies), and filtration accessories (filter holders, filter funnels, filter flasks, membrane dispensers, filter housings, cartridges, vacuum pumps, seals, and other filtration accessories).

Technology

Based on technique, the market is segmented into microfiltration, ultrafiltration, reverse osmosis, vacuum filtration, and nanofiltration. The microfiltration segment accounted for the largest share in 2018, while the ultrafiltration segment is projected to witness the highest growth during the forecast period.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=12936082

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific (APAC)
4. Latin America
5. Middle East and Africa (MEA)

Geographical Growth Analysis:

The global lab filtration market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the market. The growth of the market in North America is mainly driven by the large number of pharmaceutical & biotechnology and food & beverage companies in the region, the presence of a well-established healthcare market, and the stringent regulatory scenario in the pharmaceutical industry.

Some key players mentioned in the research report are:

Merck Millipore (US), Danaher Corporation (US), Sartorius Ag (Germany), 3M Company (US), GE Healthcare (US), GEA GROUP AKTIENGESELLSCHAFT (Germany), Cantel Medical Corporation (US), Thermo Fisher Scientific (US), Veolia Water Technologies (France), Avantor, Inc (US), GVS S.p.A (Italy), MANN+HUMMEL (Germany), Agilent Technologies, Inc (US), Ahlstrom-Munksjö (Finland), MACHEREY-NAGEL GmbH & Co. KG (Germany), AMD Manufacturing, Inc. (Canada), Koch Membrane Systems (US), Cole-Parmer (US), AQUAPORIN A/S (Denmark), and Sterlitech Corporation (US).

 The demand for transplant diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing burden of infectious diseases, the increasing number of transplant procedures, and technological advancements in the field of transplant diagnostics.

The transplant diagnostics market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%.

Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User (Hospital) - Global Forecast to 2025

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=2531061

Global Blood Glucose Monitoring System Market is Segmented on:

1. Technology
2. Product
3. Type
4. End User

Product

The market, by technology, is segmented into molecular and non-molecular assay technologies. In 2019, the molecular assay technologies segment accounted for the largest share of the market. The large share of this segment can be attributed to the benefits offered by molecular assays such as low turnaround time, high procedural efficacy, the study of multiple samples, and real-time sample analysis.

End User

Based on end user, the market is segmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. In 2019, independent reference laboratories accounted for the largest share of the market. The large share of this segment can be attributed to the rapid modernization and automation of diagnostic laboratories, growing number of research & development activities outsourced by pharmaceutical & biotechnology companies to independent reference laboratories, and the growing number of organ transplantation procedures.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=2531061

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific (APAC)
4. Latin America
5. Middle East and Africa (MEA)

Geographical Growth Analysis:

North America is a well-established market for medical devices. The presence of a highly developed healthcare system, high adoption of innovative transplant diagnostic technologies among medical professionals, the large volume of organ transplantation procedures performed in the region, and technological advancements in the field of transplant diagnostics are the major factors driving the market in North America.

Some key players mentioned in the research report are:

Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), bioMérieux SA (France), Immucor, Inc. (US), Becton, Dickinson and Company (US), Merck KGaA (Germany), and Hologic, Inc. (US).

Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT. However, a dearth of skilled professionals is restraining the growth of this market.

•    The global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from   USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period.

By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests.

The trisomy applications segment accounted for the largest share of the global NIPT market in 2018.

Based on application, the non-invasive prenatal testing (NIPT) market is segmented into trisomy, microdeletion syndrome, and other applications (gender identification and the detection of monogenic disorders, Klinefelter syndrome, and Rhesus (Rh) blood type). In 2018, trisomy was the largest application segment of the NIPT market.

Get a PDF Copy of the Sample Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690

By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests. The cfDNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to technological advancements and increasing company initiatives to develop new products.

Non-invasive Prenatal Testing Products Market, by Method

• Ultrasound Detection
• Biochemical Screening Tests
• Cell-free DNA in Maternal Plasma Tests
  
  

Non-invasive Prenatal Testing Market, by Application

• Trisomy
• Microdeletion Syndrome
• Other Applications
  
  

Non-invasive Prenatal Testing Products Market, by End User

• Diagnostic Laboratories
• Hospitals
  
  

The geographical regions mapped in the report are:

• North America
• US
• Canada
• Europe
• Germany
• France
• UK
• Rest of Europe (RoE)
• Asia
• Rest of the World (RoW)
  
  

For getting 10% customization Please click here @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=145607690

Geographically, the non-invasive prenatal testing market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2019, North America accounted for the largest market share, followed by Europe. On the other hand, Asia is expected to grow at the highest CAGR during the forecast period. The developing healthcare infrastructure, rising awareness programs & conferences, and rising focus of prominent players on expanding their presence in Asia are driving market growth in this region

Some key players mentioned in the research report are:

• The NIPT market is diversified and highly competitive, with a large number of players competing for market space. The prominent players in the market are Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), GE Healthcare (US), BGI (China), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer Inc. (US), Laboratory Corporation of America Holdings (US), Natera, Inc. (US), and Yourgene Health (UK) 
  
  
• Illumina is one of the major players in the non-invasive prenatal testing market. The company offers a range of highly interconnected products related to sequencing, genotyping, gene expression, and molecular diagnostics. It also offers whole-genome sequencing, genotyping, NIPT, and support services which further strengthen its market position.
  
  

Read more about NIPT market

@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=145607690

The overall market, by public health organization is positively impacted by factors such as the growing expenditure on drugs and medical devices by public health organizations, government initiatives to strengthen analytical testing capabilities, increasing number of drug approvals & clinical trials, and rising demand for specialized analytical testing services.

• The global analytical laboratory services market, by public health organization is projected to reach USD 333.8 Million by 2021 from USD 202.8 Million in 2016, at a CAGR of around 10.5% during the forecast period.
  
  

What Drives the Market?

1. Growing Expenditure on Drugs and Medical Devices By Public Organizations
2. Government Initiatives to Strengthen Analytical Testing Capabilities
3. Increasing Number of Drug Approvals and Clinical Trials
4. Rising Demand for Specialized Analytical Testing Services

The key trends for increase in market, by public health organization are the growing expenditure on drugs and medical devices by public health organizations, steps by the government to build up strong analytical testing abilities, increasing number of drug approvals and clinical trials, and rising demand for specialized analytical testing services.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65590498

On the basis of type of service, the spend assessment is segmented into eight segments, namely, bioanalytical testing, batch release testing, stability testing, raw material testing, physical characterization, method validation, microbial testing, and environmental monitoring. In 2015, the bioanalytical testing segment accounted for the largest share of the analytical laboratory services market, by public health organization. This growth can be attributed to factors such as the usage and development of a large number of macromolecules and Biosimilars for various therapeutic areas and the growing biopharmaceutical industry across the globe.

Target Audience :

• Government Agencies
• Nonprofit Organizations
• Analytical Laboratories
• Private Analytical Testing Providers
  
  

Scope of the Report:

The research report categorizes the market, by public health organization into the following segments:

Global Analytical Laboratory Services Market, By Public Health Organization, by Type of Service

• Bioanalytical Testing
• Batch Release Testing
• Stability Testing
• Raw Material Testing
• Physical Characterization
• Method Validation
• Microbial Testing
• Environmental Monitoring
  
  

Request Sample Pages :  https://www.marketsandmarkets.com/requestsampleNew.asp?id=65590498

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific
4. Rest of the World (RoW)

Analytical Laboratory Services Market, by public health organization is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2015, North America commanded the largest share, followed by Europe, Asia-Pacific, and the RoW. The major share of this region can be attributed to the high expenditure on quality testing, strong regulatory scenario, increasing number of clinical trials, and the well-established federal testing laboratories in the region
.

Some key players mentioned in the research report are:

Food and Drug Administration (U.S.), European Medicines Agency (U.K.), Federal Institute for Drugs and Medical Devices (Germany), Agence française de sécurité sanitaire des produits de santé (France), Agenzia Italiana del Farmaco (Italy), the Spanish Medicines and Health Products Agency (Spain), Central Drugs Standard Control Organization (India), China Food and Drug Administration, and Pharmaceuticals and Medical Devices Agency (Japan).

To get a 10% Customization on the report, click @https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=65590498

According to the new market research report ” IV Equipment Market by Product (Infusion Pump, Catheter, Solution and Blood Administration Set, Securement Device, Cannula, Stopcock, Needleless Connector), End User (Hospitals & Clinics, Homecare, Ambulatory Care Center) – Global Forecast to 2022″, published by MarketsandMarkets™,The overall IV equipment market is expected to grow from USD 10.07 billion in 2017 to USD 13.64 billion by 2022, at a CAGR of 6.2% from 2017 to 2022.

Browse in-depth TOC on “IV Equipment Market”
102 – Tables
38 – Figures
166 – Pages

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78345313

IV Equipment Market is estimated to be the largest segment for the market

The major factors driving the growth of this market include increasing incidence of chronic diseases, rapid growth in the aging population, and growing number of surgical procedures. The high growth in developing countries across Asia-Pacific and Latin America are expected to provide significant growth opportunities for players operating in the IV equipment market in the coming years. However, stringent regulatory requirements for new products and increasing incidence of medication errors and lack of wireless connectivity in most hospitals pose challenges for the growth of this market.

Target Audience :

• Medical device manufacturers and distributors
• Research and development institutions
• Hospitals and ambulatory surgery centers
• Market research and consulting firms
• Venture capitalists and investors
• Government organizations

IV catheters to hold the largest market share during the forecast period

Based on product, the IV equipment market is segmented into IV catheters, administration sets, infusion pumps, securement devices, stopcocks & check valves, drip chambers, needleless connectors, and others. In 2016, the IV catheters accounted for the largest share of the market. Increasing prevalence of chronic diseases and the growing number of surgical procedures are the key factors driving the market growth in this segment.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=78345313

North America is expected to be the fastest-growing market for IV Equipment

North America accounted for the largest share of the global IV equipment market, followed by Europe, Asia-Pacific, and RoW. This growth can be attributed to the rising geriatric population, increasing prevalence of chronic diseases, the presence of a well-established healthcare industry, growing demand for advanced medical treatments, the presence of major players, and increasing government healthcare expenditure.

Some key players mentioned in the research report are:

Becton, Dickinson and Company (U.S.), B. Braun Melsungen AG (Germany), Baxter International Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), ICU Medical, Inc. (U.S.) held the major share of the IV equipment market and will continue to dominate the market between 2017 and 2022. Other major players operating in this market are Smiths Medical (U.K.), Moog, Inc. (U.S.), Terumo Corporation (Japan.), C. R. Bard, Inc. (U.S.), and AngioDynamics, Inc. (U.S.).

Factors such as growing awareness about various health-related disorders among women, rising incidence of various chronic and lifestyle disorders in women, and high prevalence of infectious diseases such as HIV and hepatitis in women across the globe are driving the growth of the market.

The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period.

Target Audience:

• Hospitals and Clinics
• Medical Research and Development (R&D) Companies
• Medical Device Companies
• Women Health Diagnostics Solutions’ Vendors
• Medical Device Manufacturers
• Imaging and Diagnostic Centers
• Market Research and Consulting Firms
• Venture Capitalists and Investors

Women’s Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) – Forecast to 2021

Moreover, the increasing adoption of point-of-care diagnostic testing and the increasing number of diagnostic and imaging centers are also expected to play a major role in market growth. However, shortage of skilled laboratory technicians and high costs of diagnostics devices, tests, and procedures are hindering the growth of women health diagnostics market.

Scope of the Report:

The research report categorizes the women’s health diagnostics market into the following segments and subsegments:

Global women’s health diagnostics market, by application

• Breast Cancer Testing
  • Mammography Systems
  • Breast Cancer Tumor Marker Tests
  • Blood Chemistries and Blood Cell Count
  • Biopsies
  • Other Diagnostic Imaging Tests
• Infectious Disease Testing
  • Urinary Tract Infection Testing
  • MRSA Testing
  • Hepatitis Testing
  • Tuberculosis Testing
  • Other Infectious Disease Testing
• Cervical Cancer Testing
  • Pap Smear
  • HPV Testing
• Osteoporosis Testing
  • Bone Densitometry
  • In Vitro Blood Tests
• Sexually Transmitted Disease Testing
  • Chlamydia Trachomatis And Neisseria Gonorrhoeae (Ct/Ng) Testing
  • HIV Testing
  • Other Sexually Transmitted Diseases
• Prenatal Genetic Screening and Carrier Testing
  • Cystic Fibrosis
  • Down Syndrome and Edward Syndrome
  • TORCH Infections
  • Other Diseases
• Ultrasound
  • OB/GYN Imaging
  • Breast Imaging
• Pregnancy and Fertility Testing
  • Pregnancy Testing and Ovulation Prediction Kits
  • Lab-based Testing
  • Fertility Monitors
• Ovarian Cancer Testing
  • Ovarian Cancer Tumor Marker Tests
  • Diagnostic Imaging Tests
  • Other Tests

Factors such as growing drug & alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, and regulatory approvals and new product & service launches are driving the growth of the market.

Drug Screening Market by Product ((Immunoassay Analyzer, Chromatography, Breathalyzer, Rapid Test Device, Assay Kits)), Drug Screening Services, Sample Type (Urine, Hair, Oral), End User (Workplace, Criminal Justice, Hospital) – Global Forecast to 2022

The drug screening market was valued at USD 4.86 Billion in 2016 and is expected to reach USD 8.63 Billion by 2022, growing at a CAGR of 10.2% during the forecast period.

The global Drug Screening Market is Segmented on:
1. Product
2. Drug Screening Services
3. Sample Type
4. End User

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773

The objectives of this study are as follows:

• To define, describe, segment, and forecast the global market by product and service, sample type, end user, and region To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, challenges, and market-specific trends)
•  To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze the opportunities in the market for stakeholders and provide details of competitive landscape for market leaders
• To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). To profile key players and comprehensively analyze their market shares and core competencies
• To track and analyze competitive developments such as agreements, partnerships, and collaborations; acquisitions; product launches and approvals; expansions; and R&D activities in the global market.

Autoinjectors are used to self-administer drugs for the treatment of various diseases and conditions, such as rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis. Autoinjectors are easy to use, portable, and improve dosing accuracy, making them one of the most popular methods for the self-administration of drugs.

How much is the Autoinjectors Market worth?

The autoinjectors market is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2%. 

Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular diseases, Psoriasis, Migraine), Type (Disposable, and Reusable), End Users (Homecare, and Hospitals) - Global Forecast to 2023

Growth in the global autoinjectors market is mainly driven by factors such as the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, the increasing number of regulatory approvals, the availability of generic versions of autoinjectors, favorable reimbursements and government support, and technological advancements in autoinjector devices.

The patent expiry of biologics in the coming years is also expected to provide growth opportunities for players in the autoinjectors market

Download PDF Brochure @https://www.marketsandmarkets.com/requestsampleNew.asp?id=173991724

Disposable autoinjectors segment is expected to grow at the highest CAGR during the forecast period.

Disposable autoinjectors are the most-preferred autoinjectors due to their ease of use and the presence of a built-in glass syringe (eliminates the need for manually loading the glass syringe), which makes it more convenient for patients with reduced dexterity or visual impairments.

The rheumatoid arthritis segment to account for the largest share of the autoinjectors market.

The demand for Disposable Autoinjectors for this therapy segment is fueled by the increasing incidence of RA across the globe. According to the CDC, an estimated 43.7 million adults (22.7% of the total population) in the US annually are affected by some form of arthritis, RA, gout, lupus, or fibromyalgia. By 2040, an estimated 78 million (26%) US adults aged 18 years or older are projected to have doctor-diagnosed arthritis.

Request for Sample Pages @https://www.marketsandmarkets.com/requestsampleNew.asp?id=17399172

Regional Growth, Development and Demand Analysis:

North America to witness the highest market growth during the forecast period
The large share of the North American Disposable Autoinjectors can primarily be attributed to the rising prevalence of autoimmune and chronic diseases, increasing prevalence of anaphylaxis, and the increasing number of FDA approvals in the region

Critical questions the report answers:

•  Which are the most significant revenue-generating regions for the market?
• What are the significant upcoming trends in the market?
• How will the market drivers, restraints, and future opportunities affect the market dynamics?
•  Which end-user segment is expected to witness maximum growth opportunities during the forecast period?
  
  

Growing adoption of noninvasive procedures, changing lifestyles, rising incidence of skin damage, reduction in procedural costs, and rise in medical tourism devices are the major factors driving the growth of the aesthetic lasers market. However, the rising adoption of energy-based devices and low focus of market players on aesthetic/cosmetic devices are restraining the growth of this market.

•    The global aesthetic lasers market is estimated to grow at a CAGR of 10.2% during the forecast period, to reach USD 1,132.7 Million by 2021
  
  

Aesthetic/Cosmetic Lasers Market by Type (Standalone (CO2, Er:YAG, Diode, Nd:YAG, Alexandrite, Pulsed-Dye), Multiplatform), Application (Acne, Scars, Tattoo Removal, Varicose Veins), End User (Hospitals, Medical Spa, Private clinics) – Forecasts to 2021

Browse 88 market data tables and 43 figures spread through 147 pages
Download PDF Brochure

: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94673613

Primary and secondary research was used to for market estimation and forecast. Various secondary sources such as directories, industry journals, and databases have been used to identify and collect information useful for this extensive commercial study of the market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the market.

Aesthetic/Cosmetic Lasers Market segmented into :

Based on type, the aesthetic/cosmetic lasers type market is segmented into standalone lasers and multiplatform lasers. In this market, multiplatform lasers formed the fastest-growing segment as they provide scalable and upgradeable hybrid systems that can treat multiple indications.

Based on application, the aesthetic/cosmetic lasers type market is segmented into vascular lesions, acne & scars, pigmented lesions & tattoos, hair removal, skin rejuvenation, leg veins & varicose veins, and other applications (onychomycosis and gynecological conditions). The hair removal segment accounted for the largest share of the market due to factors such as high adoption of aesthetic procedures, developments in the laser technology, increased focus on body appearance, and high disposable income.

Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=94673613

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific
4. Rest of the World (RoW)

Geographical Growth Analysis:

The market is segmented into four major regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Among these regional segments, North America is expected to account for the largest share of the global aesthetic lasers market. However, the Asia-pacific is expected to grow at the highest CAGR during the forecast period. The high growth in this regional segment can be attributed to factors changing lifestyles, rising incidences of skin damage, and increasing medical tourism in the region will drive the growth of this market.

Some of The Major Players In Aesthetic/Cosmetic Lasers Market :

Industry trends such as social media marketing and increasing consolidations of manufacturers and suppliers of aesthetic lasers products is further driving the growth of this market. Major players in the aesthetic lasers market include Aerolase (U.S.), Alma Lasers, Ltd. (Israel), Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), El.En. SpA (Italy), Lumenis Ltd. (Israel), Sciton, Inc. (U.S.), SharpLight Technologies (Israel), Syneron Medical Inc. (Israel), and Solta Medical (U.S.).

• MarketsandMarkets forecasts the Genotyping Assay market to grow from USD 11.8 billion in 2018 to USD 31.9 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 22.0% during the forecast period.

• North America (US and Canada)
• Europe (Germany, France, UK, Spain, Italy and Rest of Europe)
• Asia-Pacific (China, Japan,  India and ASEAN)
• Rest of World (Latin America, Middle East & Africa)